Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Assumptions & Limitations
2.1.1 Assumptions
2.1.2 Limitations
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Share Analysis
3.4 Trade Analysis
3.5 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence of Diabetic Retinopathy and Other Eye Diseases
4.2.2 Increasing Technological Advancements
4.2.3 Multipurpose Application, which Goes Beyond Ophthalmology Use to Other Diseases
4.3 Restraint
4.3.1 High Cost
4.4 Opportunities
4.4.1 Rising approval from regulatory bodies
4.4.2 Favourable Reimbursements
4.5 Macroeconomic Indicators
5 Market Impact Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 The threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain
5.2.1 Research & Product Development
5.2.2 Component Manufacturing
5.2.3 Assembly
5.2.4 Distribution
5.3 Demand & Supply: Gap Analysis
6 Global Optical Coherence Tomography Market by Technology
6.1 Introduction
6.1.1 Spectral-domain OCT (SD-OCT)
6.1.2 Swept-source OCT
7 Global Optical Coherence Tomography Market by Application
7.1 Introduction
7.1.1 Cardiology
7.1.2 Ophthalmology
7.1.3 Dermatology
7.1.4 Oncology
8 Global Optical Coherence Tomography Market by Type of Devices
8.1 Introduction
8.1.1 Handheld OCT Devices
8.1.2 Table top OCT Devices
8.1.3 Catheter Based OCT Devices
9 Global Optical Coherence Tomography Market by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of Middle East & Africa
10 Company Landscape
10.1 Company Market Share Analysis
10.1.1 Introduction
10.2 Competitive Landscape
10.2.1 Introduction
11 Company Profiles
11.1 Carl Zeiss AG
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Products
11.1.4 Strategy
11.1.5 Key Developments
11.2 Alcon
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Products
11.2.4 Strategy
11.2.5 Key Developments
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Products
11.3.4 Strategy
11.3.5 Key Developments
11.4 Terumo Corporation
11.4.1 Company Overview
11.4.2 Financials
11.4.3 Products
11.4.4 Strategy
11.4.5 Key Developments
11.5 KONINKLIJKE PHILIPS N.V
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Products
11.5.4 Strategy
11.5.5 Key Developments
11.6 B. Braun Melsungen AG
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Products
11.6.4 Strategy
11.6.5 Key Developments
11.7 Boston Scientific Corporation
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Products
11.7.4 Strategy
11.7.5 Key Developments
11.8 Topcon Corporation
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Products
11.8.4 Strategy
11.8.5 Key Developments
11.9 NIDEK Co., Ltd.
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Products
11.9.4 Strategy
11.9.5 Key Developments
11.1 Novacam Technologies Inc.
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Products
11.10.4 Strategy
11.10.5 Key Developments
11.11 OPTOPOL Technology S.A
11.11.1 Company Overview
11.11.2 Financials
11.11.3 Products
11.11.4 Strategy
11.11.5 Key Developments
11.12 Heidelberg Engineering GmbH
11.12.1 Company Overview
11.12.2 Financials
11.12.3 Products
11.12.4 Strategy
11.12.5 Key Developments
11.13 Optovue
11.13.1 Company Overview
11.13.2 Financials
11.13.3 Products
11.13.4 Strategy
11.13.5 Key Developments
11.14 Michelson Diagnostics
11.14.1 Company Overview
11.14.2 Financials
11.14.3 Products
11.14.4 Strategy
11.14.5 Key Developments
12 Conclusion
12.1 Key Findings
12.1.1 From CEO's View Point
12.2 Key Companies to Watch
13 Appendix
13.1 Discussion Blue Print
13.2 Global Optical Coherence Tomography Market, Recent Developments (2014-2017)